Subscribe to RSS
DOI: 10.1055/s-0029-1202756
Komplementäre Verfahren bei chronisch entzündlichen Darmerkrankungen
Publication History
Publication Date:
24 February 2009 (online)

Zusammenfassung
Die konventionelle Therapie von chronisch entzündlichen Darmerkrankungen bringt oft auch Nebenwirkungen und Komplikationen mit sich. Daher suchen viele Patienten nach „sanften” Therapieverfahren. Die klassischen und erweiterten Naturheilverfahren und komplementäre Verfahren können einen wichtigen Beitrag bei der Behandlung leisten. Die wichtigsten Methoden werden hier vorgestellt und deren wissenschaftliche Validität eingeordnet.
Keywords
Chronisch entzündliche Darmerkrankungen - Colitis ulcerosa - Morbus Crohn
Literatur
- 1
Brandes JW, Stenner A, Martini GA.
Dietary habits of patients with ulcerative colitis.
Z Gastroenterol.
1997;
17
834-842
MissingFormLabel
- 2
Chapman TM, Plosker GL, Figgitt DP.
VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.
Drugs.
2006;
66
1371-87
MissingFormLabel
- 3
Chrubasik S, Pittler MH, Roufagalis BD.
Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles.
Phytomedicine.
2005;
12
684-701
MissingFormLabel
- 4
Clarke JO, Mullin GE.
A review of complementary and alternative approaches to immunomodulation.
Nutr Clin Pract.
2008;
23
49-62
MissingFormLabel
- 5 Csef H, Kraus MR. Psychosomatik in der Gastroenterologie. München, Jena; Urban und Fischer 2000
MissingFormLabel
- 6
Elsenbruch S, Langhorst J, Popkirowa K, et al..
Effects of Mind-Body therapy on Quality-of-Life and Neuroendocrine and Cellular Immune
Functions in Patients with Ulcerative Colitis.
Psychotherapy and Psychosomatics.
2005;
74
277-287
MissingFormLabel
- 7
Férnandez-Banares F, Hinojosa J, Sanches-Lombrana J, et al..
A randomized clinical trial of plantago ovata seeds as compared with mesalamine in
maintaining remission in ulcerative colitis.
Am J Gatroenterol.
1999;
2
427-433
MissingFormLabel
- 8
Gerhardt H, Seifert, Buvari P, et al..
Therapy of active Crohn’s disease with Boswellia serrata extract H15.
Z Gastroenterol.
2001;
39
11-17
MissingFormLabel
- 9
Griffith AM, Ohlsson A, Sherman PM, et al..
Metaanalysis of enteral nutrition as a primary treatment of active Crohn’s disease.
Gastroenterology.
1995;
108
1056-1067
MissingFormLabel
- 10
Guandalini S.
Probiotics for children with diarrhea: an update.
J Clin Gastroenterol.
2008;
42 Suppl 2
53-7
MissingFormLabel
- 11 Hoffmann JC, Kroesen AJ, Klump B. Chronisch entzündliche Darmerkrankungen. Das CED-Handbuch für Klinik und Praxis. Stuttgart; Thieme 2004
MissingFormLabel
- 12
Huber R, Ditfurth AV, Amann F, et al..
Tormentil for active ulcerative colitis: an open-label, dose-escalating study.
J Clin Gastroenterol.
2007;
41
797-798
MissingFormLabel
- 13
Joos S, Brinkhaus B, Maluche C, et al..
Acupuncture and Moxibustion in the treatment of active Crohn’s Disease: A randomized
controlled study.
Digestion.
2004;
69
131-139
MissingFormLabel
- 14
Joos S, Wildau N, Kohnen R, et al..
Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled
study.
Scand J Gastroenterol.
2006;
41
1056-1063
MissingFormLabel
- 15
Kruis W, Schutz E, Fric P, et al..
Doubleblind comparison of an oral E. coli preparation and mesalazine in maintaining
remission of ulcerative colitis.
Aliment Pharmacol Ther.
1997;
5
853-858
MissingFormLabel
- 16
Langhorst J, Anthonisen IB, Steder-Neukamm U, et al..
Amount of systemic steroid medication is a strong predictor for the use of complementary
and alternative medicine in German patients with Inflammatory bowel disease: Results
from a national survey.
Inflammatory Bowel Diseases.
2005;
11
287-295
MissingFormLabel
- 17
Langhorst J, Müller T, Luedtke R, Franken U, Paul A, Michalsen A, Schedlowski M, Dobos GJ, Elsenbruch S.
Effects of a comprehensive lifestyle modification Program on Quality-of-Life in Patients
with Ulcerative Colitis: A Twelve-Month Follow-Up Study.
Scand J Gastroenterol.
2007;
6
734-45
MissingFormLabel
- 18
Levenstein S, Prantera C, Varvo V, et al..
Psychological stress and disease activity in ulcerative colitis: a multidimensional
crosssectional study.
Am J Gastroenterol.
1994;
89
1219-25
MissingFormLabel
- 19
Levenstein S, Prantera C, Varvo V, et al..
Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled
in remission.
Am J Gastroenterol.
2000;
95
1213-1220
MissingFormLabel
- 20
Loudon CP, Corroll V, Butcher J, et al..
The effects of physical exercise on patients with Crohn’s disease.
Am J Gastroenterol.
1999;
94
697-703
MissingFormLabel
- 21
Masuda A, Deguchi D, Muemoto T, Nozoe S.
Autogenic training in patients with ulcerative colitis.
Psychosomatic Medicine.
2000;
62
97-152
A 1210
MissingFormLabel
- 22
Persson PG, Ahlborn A, Hellers G.
Diet and inflammatory bowel disease: a casecontrol study.
Epidemiology.
1992;
3
47-52
MissingFormLabel
- 23
Persson PG, Leijonmarck CE, Bernell O, et al..
Risk indicators for inflammatory bowel disease.
Int J Epidemiol.
1993;
22
268-272
MissingFormLabel
- 24
Sonnenberg A.
Occupational distribution of inflammatory bowel disease among German employees.
Gut.
1990;
31
1037-1040
MissingFormLabel
- 25
Stange EF, Riemann J, von Herbay A, et al..
Diagnostik und Therapie der Colitis ulcerosa: Ergebnisse einer evidenzbasierten Konsensuskonferenz
der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen.
Z Gastroenterol.
2001;
39
19-20
MissingFormLabel
- 26
Stange EF, Schreiber S, Fölsch UR, et al..
Diagnostik und Therapie des Morbus Crohn: Ergebnisse einer evidenzbasierten Konsensuskonferenz
der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen.
Z Gastroenterol.
2003;
41
19-20
MissingFormLabel
Priv.-Doz. Dr. med. Jost Langhorst
Universität Duisburg-Essen
Kliniken Essen-Mitte
Am Deimelsberg 34a
45276 Essen
Email: jost.langhorst@gmx.de